Plain-English translation of NCT06901817 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing whether a combination of two medications — pemetrexed and nivolumab — can safely and effectively treat a serious condition where lung cancer has spread to the protective lining surrounding the brain and spinal cord. Instead of taking these medications by mouth or through an IV, they will be injected directly into the fluid around your brain using a small device called an Ommaya reservoir. The study wants to learn whether this approach can help control the cancer in people who haven't responded well to other treatments.
When lung cancer spreads to the lining of the brain, it is very difficult to treat because most medications cannot reach the brain in high enough amounts. This trial is testing a new approach — delivering the medication directly where the cancer is — to see if it can work better than current options for people whose cancer has stopped responding to standard treatments.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will have a small reservoir device placed in your brain through a surgical procedure. Then, every 4 weeks, you will receive injections of the two medications directly into the fluid around your brain and spinal cord through this device, continuing until your cancer stops responding or you experience unacceptable side effects. You will also receive a dose of a steroid medication before each injection to help prevent inflammation, and you'll have regular visits to monitor your health and how well the treatment is working.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
China